{"transactions":[{"id":4613718,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:56:09.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":17056,"price":60.36,"value":1029500.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":429902,"source":{"system":"sec-edgar","filing":"0001258693-26-000019","document":"wk-form4_1788990967.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000019/wk-form4_1788990967.xml","form_type":"4"}},{"id":1435,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:57:33.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3427,"price":61.58,"value":211034.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":446958,"source":{"system":"sec-edgar","filing":"0001258693-26-000017","document":"wk-form4_1788393451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000017/wk-form4_1788393451.xml","form_type":"4"}},{"id":1434,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:57:33.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2862,"price":60.74,"value":173837.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":450385,"source":{"system":"sec-edgar","filing":"0001258693-26-000017","document":"wk-form4_1788393451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000017/wk-form4_1788393451.xml","form_type":"4"}},{"id":702193,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"exercise","planned":true,"acquired":false,"shares":16198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Option is fully vested and exercisable."}],"balance_after":137000,"derivative":{"exercise_price":2.03,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":16198},"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702192,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":378,"price":55.914,"value":21135.492,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.82 to $56.085. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":133215,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702191,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":622,"price":55.54,"value":34545.88,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.71. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":133593,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702190,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":244,"price":55.964,"value":13655.216,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.81 to $56.18. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":133215,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702189,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":756,"price":55.516,"value":41970.096,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.71. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":133459,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702188,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":4415,"price":55.931,"value":246935.365,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.77 to $56.13. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":453247,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702187,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":11783,"price":55.515,"value":654133.245,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.765. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":457662,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702186,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"exercise","planned":true,"acquired":true,"shares":16198,"price":2.03,"value":32881.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":469445,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":725465,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":191,"price":56.266,"value":10746.806,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.00 to $56.54. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":134215,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725464,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":602,"price":55.297,"value":33288.794,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.72. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":134406,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725463,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":207,"price":54.222,"value":11223.954,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.42. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":135008,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725462,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":332,"price":55.993,"value":18589.676,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.88 to $56.12. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":134215,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725461,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":356,"price":55.226,"value":19660.456,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.51. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":134547,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725460,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":312,"price":54.345,"value":16955.64,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":134903,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725459,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":6417,"price":56.121,"value":360128.457,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.815 to $56.60. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":452466,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725458,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":9137,"price":55.265,"value":504956.305,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.755 to $55.73. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":458883,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725457,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":6683,"price":54.275,"value":362719.825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.755 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":468020,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":727498,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:28:57.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy."}],"balance_after":28000,"derivative":{"exercise_price":8.35,"expiration_date":"2036-06-22","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001258693-26-000011","document":"form4-06242026_100648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258693/000125869326000011/form4-06242026_100648.xml","form_type":"4"}},{"id":732078,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":false,"shares":225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":225},"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732077,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":52.5,"value":52500.0,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":135215,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732076,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":52.5,"value":52500.0,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":135215,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732075,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":22236,"price":52.5,"value":1167390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."}],"balance_after":474703,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732074,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":225,"price":52.51,"value":11814.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."}],"balance_after":496939,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732073,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":true,"shares":225,"price":1.79,"value":402.75,"ownership":{"direct":true},"balance_after":497164,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":809574,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-13T20:55:35.000Z","date":"2026-04-09","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall be scheduled to vest monthly over a term of 24 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates."}],"balance_after":28000,"derivative":{"exercise_price":9.54,"expiration_date":"2036-04-08","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001258693-26-000008","document":"form4-04132026_080428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258693/000125869326000008/form4-04132026_080428.xml","form_type":"4"}},{"id":848661,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-03-11T21:24:54.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":3685,"price":59.32,"value":218594.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person."}],"balance_after":496939,"source":{"system":"sec-edgar","filing":"0001258693-26-000006","document":"wk-form4_1773264290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000006/wk-form4_1773264290.xml","form_type":"4"}},{"id":874073,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T01:07:45.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":175698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48 of shares subject to the option vest on March 26, 2026, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":175698,"derivative":{"exercise_price":60,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":175698},"source":{"system":"sec-edgar","filing":"0001258693-26-000004","document":"wk-form4_1772500062.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000004/wk-form4_1772500062.xml","form_type":"4"}},{"id":874072,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T01:07:45.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2531,"price":61.98,"value":156871.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":500624,"source":{"system":"sec-edgar","filing":"0001258693-26-000004","document":"wk-form4_1772500062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000004/wk-form4_1772500062.xml","form_type":"4"}},{"id":874071,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T01:07:45.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2863,"price":61.98,"value":177448.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":503155,"source":{"system":"sec-edgar","filing":"0001258693-26-000004","document":"wk-form4_1772500062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000004/wk-form4_1772500062.xml","form_type":"4"}},{"id":874070,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T01:07:45.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":105110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The\nRSUs vest as to 1/4 of the shares subject to the award on September 7, 2026 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through\neach such date."}],"balance_after":506018,"source":{"system":"sec-edgar","filing":"0001258693-26-000004","document":"wk-form4_1772500062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000004/wk-form4_1772500062.xml","form_type":"4"}},{"id":937175,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-01-16T22:10:28.000Z","date":"2026-01-14","kind":"gift","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involves the Reporting Person's transfer of shares to an irrevocable trust for estate planning purposes. The Reporting Person no longer has a pecuniary interest in the shares and therefore disclaims beneficial ownership."}],"balance_after":400908,"source":{"system":"sec-edgar","filing":"0001258693-26-000002","document":"wk-form4_1768601425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000002/wk-form4_1768601425.xml","form_type":"4"}},{"id":1043993,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-09-10T20:26:07.000Z","date":"2025-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":7356,"price":32.41,"value":238407.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":500908,"source":{"system":"sec-edgar","filing":"0001258693-25-000006","document":"wk-form4_1757535964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869325000006/wk-form4_1757535964.xml","form_type":"4"}},{"id":1047888,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-09-04T20:09:58.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3420,"price":31.56,"value":107935.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":508264,"source":{"system":"sec-edgar","filing":"0001258693-25-000004","document":"wk-form4_1757016596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869325000004/wk-form4_1757016596.xml","form_type":"4"}},{"id":1047887,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-09-04T20:09:58.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4563,"price":31.56,"value":144008.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":511684,"source":{"system":"sec-edgar","filing":"0001258693-25-000004","document":"wk-form4_1757016596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869325000004/wk-form4_1757016596.xml","form_type":"4"}},{"id":1047886,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-09-04T20:09:58.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2857,"price":31.56,"value":90166.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025."}],"balance_after":516247,"source":{"system":"sec-edgar","filing":"0001258693-25-000004","document":"wk-form4_1757016596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869325000004/wk-form4_1757016596.xml","form_type":"4"}},{"id":1124556,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-03T21:32:13.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (i) May 30, 2026, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 30, 2025. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy."}],"balance_after":20900,"derivative":{"exercise_price":0.3125,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001415889-25-015431","document":"form4-06032025_090653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258693/000141588925015431/form4-06032025_090653.xml","form_type":"4"}},{"id":1176634,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-07T11:38:05.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":false,"shares":4752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock Option is fully vested and exercisable."}],"balance_after":298360,"derivative":{"exercise_price":20.93,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":4752},"source":{"system":"sec-edgar","filing":"0001649094-25-000047","document":"wk-form4_1744025879.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000047/wk-form4_1744025879.xml","form_type":"4"}},{"id":1176633,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-07T11:38:05.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":false,"shares":15781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock Option is fully vested and exercisable."}],"balance_after":186936,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":15781},"source":{"system":"sec-edgar","filing":"0001649094-25-000047","document":"wk-form4_1744025879.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000047/wk-form4_1744025879.xml","form_type":"4"}},{"id":1176632,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-04-07T11:38:05.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":true,"shares":4752,"price":20.93,"value":99459.36,"ownership":{"direct":true},"balance_after":518775,"source":{"system":"sec-edgar","filing":"0001649094-25-000047","document":"wk-form4_1744025879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000047/wk-form4_1744025879.xml","form_type":"4"}},{"id":1176631,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-04-07T11:38:05.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":true,"shares":15781,"price":5.35,"value":84428.35,"ownership":{"direct":true},"balance_after":514023,"source":{"system":"sec-edgar","filing":"0001649094-25-000047","document":"wk-form4_1744025879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000047/wk-form4_1744025879.xml","form_type":"4"}},{"id":1235745,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T02:10:57.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":193431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48 of shares subject to the option vest on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":193431,"derivative":{"exercise_price":74.22,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":193431},"source":{"system":"sec-edgar","filing":"0001649094-25-000037","document":"wk-form4_1741054251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000037/wk-form4_1741054251.xml","form_type":"4"}},{"id":1235744,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:10:57.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":7984,"price":72.1,"value":575646.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":498242,"source":{"system":"sec-edgar","filing":"0001649094-25-000037","document":"wk-form4_1741054251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000037/wk-form4_1741054251.xml","form_type":"4"}},{"id":1235743,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:10:57.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2013,"price":73.02,"value":146989.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":506226,"source":{"system":"sec-edgar","filing":"0001649094-25-000037","document":"wk-form4_1741054251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000037/wk-form4_1741054251.xml","form_type":"4"}},{"id":1235742,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:10:57.000Z","date":"2025-03-27","kind":"grant","planned":false,"acquired":true,"shares":57938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 7, 2025 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":508239,"source":{"system":"sec-edgar","filing":"0001649094-25-000037","document":"wk-form4_1741054251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000037/wk-form4_1741054251.xml","form_type":"4"}},{"id":1337173,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-10T21:10:51.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":154,"price":93.598,"value":14414.092,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $93.355 to $93.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":136215,"source":{"system":"sec-edgar","filing":"0001649094-24-000121","document":"wk-form4_1733865045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000121/wk-form4_1733865045.xml","form_type":"4"}},{"id":1337172,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-10T21:10:51.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":1029,"price":92.032,"value":94700.928,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $91.715 to $92.63. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":136369,"source":{"system":"sec-edgar","filing":"0001649094-24-000121","document":"wk-form4_1733865045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000121/wk-form4_1733865045.xml","form_type":"4"}},{"id":1337171,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-10T21:10:51.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":222,"price":93.1,"value":20668.2,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $92.80 to $93.68. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":136215,"source":{"system":"sec-edgar","filing":"0001649094-24-000121","document":"wk-form4_1733865045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000121/wk-form4_1733865045.xml","form_type":"4"}},{"id":1337170,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-10T21:10:51.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":961,"price":92.06,"value":88469.66,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $91.615 to $92.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":136437,"source":{"system":"sec-edgar","filing":"0001649094-24-000121","document":"wk-form4_1733865045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000121/wk-form4_1733865045.xml","form_type":"4"}},{"id":1344988,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T00:15:08.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":2242,"price":94.06,"value":210882.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $93.72 to $94.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":450301,"source":{"system":"sec-edgar","filing":"0001649094-24-000115","document":"wk-form4_1733271300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000115/wk-form4_1733271300.xml","form_type":"4"}},{"id":1344987,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T00:15:08.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":1409,"price":93.061,"value":131122.949,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $92.72 to $93.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":452543,"source":{"system":"sec-edgar","filing":"0001649094-24-000115","document":"wk-form4_1733271300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000115/wk-form4_1733271300.xml","form_type":"4"}},{"id":1344986,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T00:15:08.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":11349,"price":92.06,"value":1044788.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $91.68 to $92.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":453952,"source":{"system":"sec-edgar","filing":"0001649094-24-000115","document":"wk-form4_1733271300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000115/wk-form4_1733271300.xml","form_type":"4"}},{"id":1359088,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-19T21:42:13.000Z","date":"2024-11-18","kind":"gift","planned":false,"acquired":false,"shares":710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a bona fide gift of the Issuer's Common Stock to a non-profit educational institution made via a donor advised fund."}],"balance_after":465301,"source":{"system":"sec-edgar","filing":"0001649094-24-000111","document":"wk-form4_1732052527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000111/wk-form4_1732052527.xml","form_type":"4"}},{"id":1371361,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Performance Restricted Stock Units","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"grant","planned":true,"acquired":true,"shares":80625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Represents the target number of shares of Issuer's Common Stock underlying an award of performance restricted stock units (\"PSUs\"). Each PSU represents the contingent right to receive one share of the Issuer's Common Stock. The attainment of the performance vesting condition will be based on the Issuer's percentile rank within a peer group based on total shareholder return (\"TSR\") during a four-year performance period that commenced on November 7, 2024, the Grant Date, subject to the Reporting Person's  continuous service with the Issuer through completion of the performance period. The actual number of shares of the Issuer's Common Stock deliverable with respect to the award varies based on performance and ranges from 0% to 250% of the target number of shares."}],"balance_after":80625,"derivative":{"exercise_price":0,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":80625},"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371360,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"grant","planned":true,"acquired":true,"shares":197784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the \"Grant Date\"), the Reporting Person was granted a performance stock option to purchase 197,784 shares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth and fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price))."}],"balance_after":197784,"derivative":{"exercise_price":102.7,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":197784},"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371359,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Stock Option is fully vested and exercisable."}],"balance_after":202717,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371358,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":false,"shares":14129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Stock Option is fully vested and exercisable."}],"balance_after":153198,"derivative":{"exercise_price":2.03,"expiration_date":"2028-07-23","underlying":"Common Stock","underlying_shares":14129},"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371357,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":false,"shares":663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Stock Option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.04,"expiration_date":"2025-04-23","underlying":"Common Stock","underlying_shares":663},"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371356,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":true,"shares":16000,"price":5.35,"value":85600.0,"ownership":{"direct":true},"balance_after":466011,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371355,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":true,"shares":14129,"price":2.03,"value":28681.87,"ownership":{"direct":true},"balance_after":450011,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371354,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":true,"shares":663,"price":0.04,"value":26.52,"ownership":{"direct":true},"balance_after":435882,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371353,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":105,"price":105.5,"value":11077.5,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":137398,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371352,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":434,"price":104.715,"value":45446.31,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $104.405 to $105.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":137503,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371351,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":363,"price":103.362,"value":37520.406,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $103.28 to $104.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":137937,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371350,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":281,"price":102.635,"value":28840.435,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $102.09 to $103.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":138300,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371349,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":116,"price":105.5,"value":12238.0,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":137398,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371348,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":377,"price":104.709,"value":39475.293,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $104.405 to $105.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":137514,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371347,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":463,"price":103.434,"value":47889.942,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $103.28 to $104.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":137891,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1371346,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-09T01:46:22.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":227,"price":102.68,"value":23308.36,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $102.19 to $103.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":138354,"source":{"system":"sec-edgar","filing":"0001649094-24-000105","document":"wk-form4_1731116774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000105/wk-form4_1731116774.xml","form_type":"4"}},{"id":1377136,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-04T23:46:45.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":1733,"price":108.5,"value":188030.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $107.97 to $108.93. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":435219,"source":{"system":"sec-edgar","filing":"0001649094-24-000091","document":"wk-form4_1730763998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000091/wk-form4_1730763998.xml","form_type":"4"}},{"id":1377135,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-04T23:46:45.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":3312,"price":107.339,"value":355506.768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $106.865 to $107.845. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":436952,"source":{"system":"sec-edgar","filing":"0001649094-24-000091","document":"wk-form4_1730763998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000091/wk-form4_1730763998.xml","form_type":"4"}},{"id":1377134,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-04T23:46:45.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":9955,"price":106.35,"value":1058714.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $105.855 to $106.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":440264,"source":{"system":"sec-edgar","filing":"0001649094-24-000091","document":"wk-form4_1730763998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000091/wk-form4_1730763998.xml","form_type":"4"}},{"id":1389305,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-09T00:32:26.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":537,"price":110.204,"value":59179.548,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $110.16 to $111.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":138581,"source":{"system":"sec-edgar","filing":"0001649094-24-000080","document":"wk-form4_1728433940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000080/wk-form4_1728433940.xml","form_type":"4"}},{"id":1389304,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-09T00:32:26.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":1849,"price":109.429,"value":202334.221,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $109.16 to $110.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":139118,"source":{"system":"sec-edgar","filing":"0001649094-24-000080","document":"wk-form4_1728433940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000080/wk-form4_1728433940.xml","form_type":"4"}},{"id":1389303,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-09T00:32:26.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":807,"price":108.748,"value":87759.636,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $108.14 to $109.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":140967,"source":{"system":"sec-edgar","filing":"0001649094-24-000080","document":"wk-form4_1728433940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000080/wk-form4_1728433940.xml","form_type":"4"}},{"id":1389302,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-09T00:32:26.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":356,"price":107.496,"value":38268.576,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $107.08 to $108.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":141774,"source":{"system":"sec-edgar","filing":"0001649094-24-000080","document":"wk-form4_1728433940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000080/wk-form4_1728433940.xml","form_type":"4"}},{"id":1389301,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-09T00:32:26.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":239,"price":110.348,"value":26373.172,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $110.235 to $111.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":138581,"source":{"system":"sec-edgar","filing":"0001649094-24-000080","document":"wk-form4_1728433940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000080/wk-form4_1728433940.xml","form_type":"4"}},{"id":1389300,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-09T00:32:26.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":2113,"price":109.583,"value":231548.879,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $109.17 to $110.16. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":138820,"source":{"system":"sec-edgar","filing":"0001649094-24-000080","document":"wk-form4_1728433940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000080/wk-form4_1728433940.xml","form_type":"4"}},{"id":1389299,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-09T00:32:26.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":887,"price":108.723,"value":96437.301,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $108.11 to $109.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":140933,"source":{"system":"sec-edgar","filing":"0001649094-24-000080","document":"wk-form4_1728433940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000080/wk-form4_1728433940.xml","form_type":"4"}},{"id":1389298,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-09T00:32:26.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":310,"price":107.268,"value":33253.08,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $107.08 to $108.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":141820,"source":{"system":"sec-edgar","filing":"0001649094-24-000080","document":"wk-form4_1728433940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000080/wk-form4_1728433940.xml","form_type":"4"}},{"id":1391949,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Stock Option is fully vested and exercisable."}],"balance_after":218717,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391948,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Stock Option is fully vested and exercisable."}],"balance_after":238717,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391947,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":5474,"price":114.982,"value":629411.468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $114.80 to $115.32. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":450219,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391946,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":9627,"price":114.281,"value":1100183.187,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $113.76 to $114.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":455693,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391945,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":4899,"price":113.37,"value":555399.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $112.745 to $113.735. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":465320,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391944,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":5.35,"value":107000.0,"ownership":{"direct":true},"balance_after":470219,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391943,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":6266,"price":114.934,"value":720176.444,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $114.705 to $115.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":450219,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391942,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":9429,"price":114.203,"value":1076820.087,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $113.705 to $114.68. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":456485,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391941,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":4305,"price":113.346,"value":487954.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $112.705 to $113.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":465914,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391940,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":5.35,"value":107000.0,"ownership":{"direct":true},"balance_after":470219,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391939,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":4288,"price":114.985,"value":493055.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $114.77 to $115.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":450219,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391938,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":7088,"price":114.273,"value":809967.024,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $113.76 to $114.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":454507,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1391937,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:17:31.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":3624,"price":113.381,"value":410892.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $112.76 to $113.735. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":461595,"source":{"system":"sec-edgar","filing":"0001649094-24-000077","document":"wk-form4_1727986643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000077/wk-form4_1727986643.xml","form_type":"4"}},{"id":1413914,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-09-05T21:18:01.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":13669,"price":110.15,"value":1505640.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person."}],"balance_after":465219,"source":{"system":"sec-edgar","filing":"0001649094-24-000064","document":"wk-form4_1725571075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000064/wk-form4_1725571075.xml","form_type":"4"}},{"id":1423249,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-26T20:58:19.000Z","date":"2024-08-23","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Stock Option is fully vested and exercisable."}],"balance_after":167327,"derivative":{"exercise_price":2.03,"expiration_date":"2028-07-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001649094-24-000056","document":"wk-form4_1724705892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000056/wk-form4_1724705892.xml","form_type":"4"}},{"id":1423248,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-08-26T20:58:19.000Z","date":"2024-08-23","kind":"sale","planned":true,"acquired":false,"shares":8314,"price":79.2526,"value":658906.1164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $78.985 to $79.56. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":478888,"source":{"system":"sec-edgar","filing":"0001649094-24-000056","document":"wk-form4_1724705892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000056/wk-form4_1724705892.xml","form_type":"4"}},{"id":1423247,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-08-26T20:58:19.000Z","date":"2024-08-23","kind":"sale","planned":true,"acquired":false,"shares":6686,"price":78.651,"value":525860.586,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $77.98 to $78.975. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":487202,"source":{"system":"sec-edgar","filing":"0001649094-24-000056","document":"wk-form4_1724705892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000056/wk-form4_1724705892.xml","form_type":"4"}},{"id":1423246,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-08-26T20:58:19.000Z","date":"2024-08-23","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":2.03,"value":30450.0,"ownership":{"direct":true},"balance_after":493888,"source":{"system":"sec-edgar","filing":"0001649094-24-000056","document":"wk-form4_1724705892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000056/wk-form4_1724705892.xml","form_type":"4"}}],"next_cursor":"2024-08-26T20:58:19.000000Z,1423246"}